Convene Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.15 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth -6.40%
- Profit Growth 1.27%
- Ebitda -1.87%
- Net Worth 24.89%
- Total Assets 56.77%
About Convene Pharma
Convene Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2017 (Seven years and five months 24 days old ). Its registered office is in Shimla, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.15 M.
The company currently has active open charges totaling ₹3.50 M.
Sushil Kumar and Poonam Devi serve as directors at the Company.
Company Details
-
Location
Shimla, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100HP2017PTC006708
-
Company No.
006708
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Aug 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Convene Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Kumar
|
Director | 21-Aug-2017 | Current |
|
Poonam Devi
|
Director | 21-Aug-2017 | Current |
Financial Performance of Convene Pharma.
Convene Pharma Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 6.4% decrease. The company also saw a slight improvement in profitability, with a 1.27% increase in profit. The company's net worth Soared by an impressive increase of 24.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Convene Pharma?
In 2021, Convene Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2022 | Hdfc Bank Limited | ₹3.50 M | Open |
How Many Employees Work at Convene Pharma?
Unlock and access historical data on people associated with Convene Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Convene Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Convene Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.